Skip to main content

Many Teens Overdose on Meds Prescribed for ADHD, Anxiety

 

MONDAY, March 14, 2022 (HealthDay News) -- Taken correctly, prescription drugs used to treat attention-deficit/hyperactivity disorder (ADHD) can help teens and young adults navigate their condition, but a new study finds many are dying from overdosing on these medications.

In 2019, benzodiazepines like Xanax and stimulants like Adderall accounted for more than 700 and 900 overdose deaths, respectively, in the United States, according to the U.S. Centers for Disease Control and Prevention.

"In recent years, there has been considerable attention devoted to risks of addiction associated with diverted or illicitly obtained benzodiazepines and stimulants," said senior researcher Dr. Mark Olfson. He is a professor of psychiatry, medicine and law at Columbia University Irving Medical Center in New York City.

"The new study serves as a reminder that prescription benzodiazepines and stimulants also pose overdose risks to the patients who are prescribed them," Olfson said.

Sadly, many of the overdose deaths among teens and young adults who had prescriptions for these drugs are intentional suicides, he added.

The upshot of the finding? Doctors and parents need to be careful about prescribing and having their kids take these drugs.

"Prior to prescribing benzodiazepines or stimulants to young people, physicians should assess the patient's self-injury risk and consider other treatment options for youth who have substantial risk," Olfson advised.

"Parents also have an important role in preventing suicidal behavior in their adolescent and young adult children, especially if the young person is going through a stressful period," he added. "This can involve parents being attentive to changes in the youth's behavior, listening to them, being supportive rather than intrusive, taking suicidal threats seriously, and helping them to locate professional help if necessary."

For the study, Olfson and his colleagues collected data on privately insured youths aged 15 to 24 who were seen in emergency rooms for overdosing on benzodiazepines or stimulants from 2016 through 2018. The investigators then identified who among these patients had a doctor's prescription for these drugs.

The researchers found that 29% of the overdose deaths from benzodiazepines were among youths who had a doctor's prescription for the drug in the month before overdosing, as did 25% of those who died from an overdose of a stimulant.

Continue reading


Comments

Popular posts from this blog

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable

The safety of aspartame is under review by WHO after conflicting findings.

Aspartame, a sweetener with health effects Since 1981, the WHO expert committee on additives has confirmed the safety of aspartame consumption within acceptable daily limits. The international organization has established that the acceptable daily intake (ADI) of aspartame is 40 milligrams per kilogram of body weight. This means that a person can consume up to 40 mg of aspartame per kilogram of their body weight per day without risking their health. For example, if someone weighs 60 kilos, the allowable amount of aspartame would be 2,400 milligrams (40 mg/kg x 60 kg). In recent years, several studies have been carried out on the effects of aspartame on health. The Food and Drug Administration (FDA) has reviewed the scientific evidence related to the safety of this sweetener five times since its approval in 1981, and has concluded that it remains safe for use. However, it is being studied again. It has an especially important use in low-calorie beverages consumed by children and pregnan

Light Therapy holds promise as a treatment for Alzheimer's Disease

A new article, conducted by Lili Zang and colleagues from Weifang Medical University School of Nursing in Shandong Province, China, discusses a meta-analysis of 15 high-quality trials that investigated the impact of light therapy on individuals with Alzheimer’s disease (AD). The meta-analysis included 598 patients with mild to moderate Alzheimer’s disease, and it covered 15 randomized controlled trials conducted in seven different countries. Those trials were published between 2005 and 2022. Sleep Improvement Light therapy led to significant improvements in several sleep measures. It notably enhanced sleep efficiency, increased interdaily stability, and reduced intradaily variability, all of which are indicators of better sleep quality. Light therapy was associated with a reduction in agitation, depression, and caregiver burden among individuals with Alzheimer’s disease. A significant advantage over usual care was shown in reducing the severity of psychobehavioral symptoms, as assessed